BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis
NASDAQ:BWAY - Nasdaq - US10501L1061 - ADR - Currency: USD
We assign a fundamental rating of 6 out of 10 to BWAY. BWAY was compared to 190 industry peers in the Health Care Equipment & Supplies industry. BWAY has an excellent financial health rating, but there are some minor concerns on its profitability. BWAY is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
BWAY had positive earnings in the past year.
BWAY had a positive operating cash flow in the past year.
BWAY had negative earnings in each of the past 5 years.
In multiple years BWAY reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of BWAY (2.08%) is better than 73.94% of its industry peers.
BWAY has a Return On Equity of 3.41%. This is in the better half of the industry: BWAY outperforms 76.06% of its industry peers.
BWAY's Return On Invested Capital of 1.52% is fine compared to the rest of the industry. BWAY outperforms 70.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.08% | ||
| ROE | 3.41% | ||
| ROIC | 1.52% |
ROA(3y)-11.97%
ROA(5y)-15.68%
ROE(3y)-16.92%
ROE(5y)-24.18%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 3.88%, BWAY is doing good in the industry, outperforming 75.53% of the companies in the same industry.
BWAY has a better Operating Margin (2.96%) than 68.62% of its industry peers.
Looking at the Gross Margin, with a value of 74.57%, BWAY belongs to the top of the industry, outperforming 85.11% of the companies in the same industry.
BWAY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.96% | ||
| PM (TTM) | 3.88% | ||
| GM | 74.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.4%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
BWAY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BWAY has been increased compared to 1 year ago.
BWAY has more shares outstanding than it did 5 years ago.
BWAY has a better debt/assets ratio than last year.
2.2 Solvency
BWAY has an Altman-Z score of 4.03. This indicates that BWAY is financially healthy and has little risk of bankruptcy at the moment.
BWAY's Altman-Z score of 4.03 is fine compared to the rest of the industry. BWAY outperforms 72.87% of its industry peers.
BWAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.03 |
ROIC/WACC0.17
WACC9.19%
2.3 Liquidity
A Current Ratio of 4.52 indicates that BWAY has no problem at all paying its short term obligations.
With a decent Current ratio value of 4.52, BWAY is doing good in the industry, outperforming 73.94% of the companies in the same industry.
A Quick Ratio of 4.23 indicates that BWAY has no problem at all paying its short term obligations.
BWAY has a better Quick ratio (4.23) than 76.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.52 | ||
| Quick Ratio | 4.23 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 116.74% over the past year.
Looking at the last year, BWAY shows a very strong growth in Revenue. The Revenue has grown by 34.17%.
The Revenue has been growing by 14.15% on average over the past years. This is quite good.
EPS 1Y (TTM)116.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)34.17%
Revenue growth 3Y12.95%
Revenue growth 5Y14.15%
Sales Q2Q%25.47%
3.2 Future
The Earnings Per Share is expected to grow by 61.59% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 24.66% on average over the next years. This is a very strong growth
EPS Next Y149.31%
EPS Next 2Y71.81%
EPS Next 3Y61.59%
EPS Next 5YN/A
Revenue Next Year28.34%
Revenue Next 2Y23.43%
Revenue Next 3Y24.66%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 41.35 indicates a quite expensive valuation of BWAY.
Based on the Price/Earnings ratio, BWAY is valued a bit cheaper than 69.15% of the companies in the same industry.
BWAY's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 29.63.
A Price/Forward Earnings ratio of 13.67 indicates a correct valuation of BWAY.
Based on the Price/Forward Earnings ratio, BWAY is valued cheaper than 89.89% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. BWAY is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.35 | ||
| Fwd PE | 13.67 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BWAY indicates a somewhat cheap valuation: BWAY is cheaper than 65.96% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BWAY indicates a rather cheap valuation: BWAY is cheaper than 81.91% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.91 | ||
| EV/EBITDA | 64.46 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BWAY's earnings are expected to grow with 61.59% in the coming years.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y71.81%
EPS Next 3Y61.59%
5. Dividend
5.1 Amount
No dividends for BWAY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:BWAY (2/21/2025, 8:04:42 PM)
10.75
-0.53 (-4.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners5.22%
Inst Owner Change79.86%
Ins Owners16.75%
Ins Owner ChangeN/A
Market Cap202.27M
Analysts85.71
Price Target0.08 (-99.26%)
Short Float %0.4%
Short Ratio1.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.49%
Min Revenue beat(2)0.15%
Max Revenue beat(2)0.82%
Revenue beat(4)3
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)1.95%
Revenue beat(8)5
Avg Revenue beat(8)-16.54%
Revenue beat(12)5
Avg Revenue beat(12)-35.04%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.41%
PT rev (3m)2.79%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)21.48%
EPS NY rev (1m)138.71%
EPS NY rev (3m)114.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.35 | ||
| Fwd PE | 13.67 | ||
| P/S | 5.24 | ||
| P/FCF | 33.91 | ||
| P/OCF | 21.8 | ||
| P/B | 4.59 | ||
| P/tB | 4.59 | ||
| EV/EBITDA | 64.46 |
EPS(TTM)0.26
EY2.42%
EPS(NY)0.79
Fwd EY7.31%
FCF(TTM)0.32
FCFY2.95%
OCF(TTM)0.49
OCFY4.59%
SpS2.05
BVpS2.34
TBVpS2.34
PEG (NY)0.28
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.08% | ||
| ROE | 3.41% | ||
| ROCE | 1.93% | ||
| ROIC | 1.52% | ||
| ROICexc | 8.01% | ||
| ROICexgc | 8.01% | ||
| OM | 2.96% | ||
| PM (TTM) | 3.88% | ||
| GM | 74.57% | ||
| FCFM | 15.44% |
ROA(3y)-11.97%
ROA(5y)-15.68%
ROE(3y)-16.92%
ROE(5y)-24.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.4%
GM growth 5Y-1.11%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 236.31% | ||
| Cap/Sales | 8.58% | ||
| Interest Coverage | 4.5 | ||
| Cash Conversion | 364.42% | ||
| Profit Quality | 397.67% | ||
| Current Ratio | 4.52 | ||
| Quick Ratio | 4.23 | ||
| Altman-Z | 4.03 |
F-Score7
WACC9.19%
ROIC/WACC0.17
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y149.31%
EPS Next 2Y71.81%
EPS Next 3Y61.59%
EPS Next 5YN/A
Revenue 1Y (TTM)34.17%
Revenue growth 3Y12.95%
Revenue growth 5Y14.15%
Sales Q2Q%25.47%
Revenue Next Year28.34%
Revenue Next 2Y23.43%
Revenue Next 3Y24.66%
Revenue Next 5YN/A
EBIT growth 1Y112.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year131.03%
EBIT Next 3Y39.92%
EBIT Next 5YN/A
FCF growth 1Y216.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y334.89%
OCF growth 3YN/A
OCF growth 5YN/A